While You Were at the Bench: Week 44

The hole in the ozone layer over Antartica reached its smallest maximal size in the last two decades.  NASA and NOA scientists believe the warmer temperatures in the Antartic this year helped reduce the damage to the ozone layer caused by chlorofluorocarbons.

Researchers have engineered a macromolecule that not only inhibits the IgE-Fc Receptor but also dissociates preformed ligand-receptor complexes. This could lead to a new class of fast-acting medication for acute allergic reactions.

Researchers at Stanford University have created the first all carbon solar cell.  While they acknowledge the efficiency (< 1%) is considerably lower than commercially available photovoltaic solar cells, the carbon-based thin film technique can dramatically reduce the cost associated with solar cells.

We already know that redhead, fair skinned individuals are more susceptible to melanoma caused by ultraviolet radiation.  However, new research in ginger mice suggests redheads might develop melanoma through a mechanism of oxidative damage without exposure to the sun.

Researchers at UC Santa Barbara have discovered that Notch signaling is essential for determining cell fate during embryogenesis in C. elegans.  Blocking this signal could lead to new ways of “growing” replacement organs for humans.

And in an update to a former post, the International Thermonuclear Experimental Reactor (ITER) is being delayeddue to a complicated contract process.  The first scheduled energy producing experiments aren’t scheduled until 2027 or 2028.

A great place to go for a run.

Researchers in Montreal have shown that middle-aged, overweight individuals who exercised four days a week for four months not only lost weight, but also improved their cognitive function.  Now, put down that plate of poutine, visit RateMyPI.com, and hit the gym.

Have a great weekend!

Tags: , , , , , , , , , , , , , , , ,

About Kevin Hascup

Kevin obtained his B.S. in Biochemistry from the University of Delaware in 2001.  He worked in Research & Development for Dade Behring, a clinical diagnostics company located in Newark, Delaware.  It was here that he acquired an interest in neurobiology and in the summer of 2003 he began the PhD program at the University of Kentucky.  In 2007, Kevin obtained his PhD in Anatomy and Neurobiology and continued his thesis research  with two  separate postdoctoral research positions at the Karolinska Institute in Stockholm, Sweden and McGill University in Montreal, Quebec.  Kevin is currently Director of Product Development for an up-and-coming biotechnology located in Springfield, Illinois and is co-founder of RateMyPI.com. 
This entry was posted in While You Were at the Bench and tagged , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>